Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Europe Cardiac Pacemaker Market, published by KBV research, the Europe Cardiac Pacemaker Market would witness market growth of 6.5% CAGR during the forecast period (2018 – 2024).
The Germany market would dominate the Europe Hospitals Cardiac Pacemaker Market by Country 2024; growing at a CAGR of 5.7 % during the forecast period. The UK market is expected to witness a CAGR of 5.4% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 7.7% during (2018 - 2024).
The Implantable Cardiac Pacemakers market dominated the Europe Cardiac Pacemaker Market by Product 2017, thereby, achieving a market value of $1,383.3 million by 2024, The External Cardiac Pacemaker market is expected to witness highest CAGR of 7.3% during (2018 - 2024).
The Single-Chamber Cardiac Pacemakers market dominated the Russia Cardiac Pacemaker Market by Technology 2017, growing at a CAGR of 6.4 % during the forecast period. The Dual-Chamber Cardiac Pacemakers market is expected to witness a CAGR of 7.4% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
Europe Cardiac Pacemaker Market Segmentation
By End User
Unique Offerings from KBV Research